Hepatocyte Microbeads for Acute Liver Failure

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions
Acute Liver Failure
Interventions
BIOLOGICAL

HMB002

The solution containing microbeads will be infused manually into the peritoneal cavity under ultrasound guidance, with usually a 50ml syringe, as a single infusion or several infusions, to achieve in excess of 25 million hepatocytes per kilogram of the body weight.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

King's College Hospital NHS Trust

OTHER